ME
McIlrath & Eck’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31
| Closed | -$1.46K | – | 987 |
|
|
2024
Q3 | $1.46K | Hold |
31
| – | – | ﹤0.01% | 885 |
|
|
2024
Q2 | $1.67K | Hold |
31
| – | – | ﹤0.01% | 837 |
|
|
2024
Q1 | $2.11K | Hold |
31
| – | – | ﹤0.01% | 817 |
|
|
2023
Q4 | $1.94K | Hold |
31
| – | – | ﹤0.01% | 807 |
|
|
2023
Q3 | $1.41K | Hold |
31
| – | – | ﹤0.01% | 794 |
|
|
2023
Q2 | $1.74K | Hold |
31
| – | – | ﹤0.01% | 792 |
|
|
2023
Q1 | $1.4K | Hold |
31
| – | – | ﹤0.01% | 814 |
|
|
2022
Q4 | $1.26K | Hold |
31
| – | – | ﹤0.01% | 781 |
|
|
2022
Q3 | $2K | Hold |
31
| – | – | ﹤0.01% | 751 |
|
|
2022
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 732 |
|
|
2022
Q1 | $2K | Hold |
31
| – | – | ﹤0.01% | 723 |
|
|
2021
Q4 | $2K | Hold |
31
| – | – | ﹤0.01% | 714 |
|
|
2021
Q3 | $3K | Hold |
31
| – | – | ﹤0.01% | 685 |
|
|
2021
Q2 | $5K | Hold |
31
| – | – | ﹤0.01% | 616 |
|
|
2021
Q1 | $4K | Buy |
+31
| New | +$4K | ﹤0.01% | 612 |
|